CCG-273463 structure
|
Common Name | CCG-273463 | ||
|---|---|---|---|---|
| CAS Number | 2750413-99-9 | Molecular Weight | 521.41 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C26H25BrN4O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CCG-273463CCG-273463 is a potent, selective and covalent GRK5 inhibitor with an IC50 value of 9 nM. CCG-273463 can be used in the research of heart failure, hypertrophic cardiomyopathy, and cancer[1]. |
| Name | CCG-273463 |
|---|
| Description | CCG-273463 is a potent, selective and covalent GRK5 inhibitor with an IC50 value of 9 nM. CCG-273463 can be used in the research of heart failure, hypertrophic cardiomyopathy, and cancer[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 8.6 nM (GRK5), 12 μM (GRK2)[1]. |
| In Vitro | CCG-273463 (0.02-1 μM) potently and highly inhibits GRK5 (IC50: 9 nM), with inhibitory rate of 93% (GRK5) and 97% (GRK6) at 1 μM[1]. |
| References |
| Molecular Formula | C26H25BrN4O3 |
|---|---|
| Molecular Weight | 521.41 |